U.S. mass tort: Philips CPAP recall liti… | DrugsMonitor.com

Philips CPAP recall litigation —primer on claims in play, court posture, key deadlines, and a confidential attorney review—not legal advice.

PE-PUR foam, BiPAP, sleep apnea devices, respiratory injury

Philips recalled millions of CPAP, BiPAP, and ventilator devices after degraded polyester-polyurethane (PE-PUR) sound-abatement foam could release particles or volatile chemicals. Users allege respiratory injury, cancer, and other harms.

Recall background

FDA classified the recall as Class I for many units—the most serious level—citing potential toxic and carcinogenic effects from foam breakdown, especially with ozone cleaning or high heat/humidity storage.

Plaintiffs assert design defect, failure to warn, and negligence; defendants dispute injury causation and exposure levels.

FAQ

Philips CPAP Device 诉讼是关于什么的?

此页面总结了 飞利浦 CPAP 召回诉讼 的公开诉讼背景和安全背景。它是教育性的——不是对您个人的案例评估。

此页面是法律建议吗?

不是。DrugsMonitor.com 不是律师事务所。此处没有任何内容告诉您是否拥有索赔权或您应该采取什么法律行动。

如何申请保密审查?

使用此页面上的信息收集或「申请保密审查」选项。只有在您选择继续时,才可能将您转介至合作伙伴律所。